Cargando…
Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine
Major depressive disorder (MDD) has a prevalence of 5% in adolescents. Several studies have described the association between the inflammatory response and MDD, but little is known about the relationship between MDD and growth factors, such as IL-7, IL-9, IL-17A, VEGF, basic FGF, G-CSF, and GM-CSF....
Autores principales: | Becerril-Villanueva, Enrique, Pérez-Sánchez, Gilberto, Alvarez-Herrera, Samantha, Girón-Pérez, Manuel Iván, Arreola, Rodrigo, Cruz-Fuentes, Carlos, Palacios, Lino, de la Peña, Francisco R., Pavón, Lenin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885844/ https://www.ncbi.nlm.nih.gov/pubmed/31827384 http://dx.doi.org/10.1155/2019/9130868 |
Ejemplares similares
-
Serum levels of chemokines in adolescents with major depression treated with fluoxetine
por: de la Peña, Francisco Rafael, et al.
Publicado: (2020) -
Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study
por: Pérez-Sánchez, Gilberto, et al.
Publicado: (2018) -
Immunomodulatory Effects Mediated by Dopamine
por: Arreola, Rodrigo, et al.
Publicado: (2016) -
Immunomodulatory Effects Mediated by Serotonin
por: Arreola, Rodrigo, et al.
Publicado: (2015) -
Imipramine Administration in Brucella abortus 2308-Infected Mice Restores Hippocampal Serotonin Levels, Muscle Strength, and Mood, and Decreases Spleen CFU Count
por: Maldonado-García, José Luis, et al.
Publicado: (2023)